These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 16163494
21. Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease. Choudhary A, Harding SP, Bucknall RC, Pearce IA. J Ocul Pharmacol Ther; 2006 Jun; 22(3):168-75. PubMed ID: 16808677 [Abstract] [Full Text] [Related]
22. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report]. Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA. Przegl Lek; 2006 Jun; 63 Suppl 3():44-8. PubMed ID: 16898486 [Abstract] [Full Text] [Related]
27. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial. Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR, FAST Research Group. JAMA; 2019 Sep 10; 322(10):936-945. PubMed ID: 31503307 [Abstract] [Full Text] [Related]
28. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. Zachou K, Gatselis N, Papadamou G, Rigopoulou EI, Dalekos GN. J Hepatol; 2011 Sep 10; 55(3):636-646. PubMed ID: 21238519 [Abstract] [Full Text] [Related]
34. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center. Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T. Clin Nephrol; 2009 Oct 10; 72(4):268-73. PubMed ID: 19825332 [Abstract] [Full Text] [Related]
35. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus. Mino Y, Naito T, Shimoyama K, Ogawa N, Kawakami J. Ann Clin Biochem; 2017 Jul 10; 54(4):490-494. PubMed ID: 27538768 [Abstract] [Full Text] [Related]
36. Mycophenolate mofetil as an immunomodulator in refractory noninfectious uveitis. Rodriguez EE, Sakata VM, Cavalcanti DC, Zaghetto JM, Olivalves E, Hirata CE, Yamamoto JH. Arq Bras Oftalmol; 2016 Jul 10; 79(6):369-372. PubMed ID: 28076562 [Abstract] [Full Text] [Related]
37. Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. Adler YD, Mansmann U, Zouboulis CC. Dermatology; 2001 Jul 10; 203(4):322-4. PubMed ID: 11752821 [Abstract] [Full Text] [Related]